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Objective: The 30-day operative mortality for thoracotomy in lung cancer is
described herein. Methods: From January 1994 through December 1994, the
Japanese Association for Chest Surgery surveyed the number of thoracot-
omies for lung cancer by operative procedure, age, and operative mortality.
The operative mortality was defined as death within 30 days of operation.
Results: The total number of operations was 7099. The overall 30-day
operative mortality was 1.3%. By operative procedure, the mortalities were
3.2% for pneumonectomy, 1.2% for lobectomy, and 0.8% for a lesser
operation, which showed a significant difference between pneumonectomy
and lobectomy (p <0.01). The mortality by age was 0.4% for patients
younger than 60 years, 1.3% for those aged 60 to 69, 2.0% for those aged 70
to 79, and 2.2% for those aged 80 or older, which showed significant
differences between the less than 60-year and 60- to 69-year-old groups, and
between the 60- and 69-year-old and 70- and 79-year-old groups (p < 0.01
and p 5 0.047, respectively). Pneumonia and respiratory failure caused
most deaths (51.6%). Conclusions: The operative mortality in Japan for
thoracotomy in lung cancer was satisfactorily low. The results of this study
on a large population could serve as a standard when discussing the
operative outcome of lung cancer. (J Thorac Cardiovasc Surg 1998;115:
70-3)
Today, lung cancer is one of the major causes ofdeath. Evaluation of the operative outcome
thereof is important to improve operative proce-
dures and increase patients’ quality of life by select-
ing an optimal therapy.
The 30-day operative mortality in 2220 lung can-
cer cases in North America was reported in 19831
and, to date, has been referred to as the standard.
It has been more than 10 years, and the periop-
erative management has improved. From this, it
may be natural to anticipate a more favorable
operative outcome. Although several investigators
have reported their operative mortalities in a pop-
ulation of several hundred cases,2, 3 in the aged
groups,2-7 or in cases with limited operative proce-
dures,8, 9 and various stages,10, 11 no one has made a
survey of the operative mortality of lung cancer in a
large population comprised of several thousand
cases, except for one.12
This article reports on the Japanese Association
for Chest Surgery 30-day study of operative deaths
after thoracotomy in more than 7000 lung cancer
cases in a 1-year period. The overall profile of
Japanese lung cancer surgery is described, and a
standard for comparing operative results in world-
wide series is provided.
Patients and methods.
The Japanese Association for Chest Surgery is the only
medical association in which almost all Japanese institu-
tions related to lung cancer surgery participate. In this
study, the association distributed questionnaires to 312
member institutions and analyzed valid data returned
from 200 institutions. The disease for analysis was lung
cancer, regardless of whether it is primary or recurrent.
The observation period was from January 1994 through
December 1994. The data were collected and analyzed
retrospectively.
The number of operations, number of deaths, and
mortalities were analyzed according to the operative
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procedure and age, and the causes of operative deaths
were summarized. The operative procedures were divided
into pneumonectomy, lobectomy, and less invasive oper-
ations (segmentectomy, partial resection, exploratory tho-
racotomy, and so on). Video-assisted thoracoscopic sur-
gery was not included. Ages of the participants were
divided into less than 60 years old, 60 to 69 years old, 70
to 79 years old, and 80 years and older. The operative
mortality was defined as death within 30 days of opera-
tion.
Statistical analysis was performed by goodness test of fit
for x2 and x2 test for independence with a Stat View-J4.02
(Abacus Concepts, Berkeley, Calif.). A p value less than
0.05 was considered significant.
Results
The total number of thoracotomies for lung can-
cer performed at 200 member institutions during 1
year was 7099. Institutions performing fewer than 40
thoracotomies per year occupied more than 65%
(135/200). On the other hand, those performing 100
or more thoracotomies per year were less than 5%
(8/200). The mean number of operations per insti-
tution was 35.5. Ninety-three deaths occurred within
30 days after operation in 7099 cases, with a 30-day
operative mortality of 1.3%.
Pneumonectomy was performed on 586 patients
(8.3%), lobectomy on 5609 (79.0%), and less inva-
sive operations on 904 (12.7%). Nineteen patients
died after pneumonectomy (3.2%), 67 after lobec-
tomy (1.2%), and 7 after a less invasive operation
(0.8%). A significant difference in operative mortal-
ity was observed between pneumonectomy and lo-
bectomy (p , 0.01) (Table I).
The number of operations by age and the propor-
tion of all the operations was 1893 (26.7%) for the
group less than 60 years old, 2876 (40.5%) for the
group 60 to 69 years old, 2105 (29.7%) for the group
70 to 79 years old, and 225 (3.2%) for the group 80
years old or older. The number of deaths and 30-day
operative mortality by age were 7 (0.4%) for the
group less than 60 years old, 38 (1.3%) for the group
60 to 69 years old, 43 (2.0%) for the group 70 to 79
years old, and 5 (2.2%) for the group 80 years old or
older. The number of deaths in patients 70 years old
or older was 48 (2.1%). Significant differences were
observed between the groups less than 60 and 60 to
69 years old and between the groups 60 to 69 and 70
to 79 years old (p , 0.01 and p 5 0.047, respectively)
(Table II).
The causes of death within 30 days after operation
are shown in Table III. Pneumonia and respiratory
failure accounted for most deaths (n 5 48, 51.6%),
followed by cardiac complications, postoperative
hemorrhage, and bronchopleural fistula/empyema
in that order.
Discussion
Lung cancer is one of the major causes of death in
many developed countries, including Japan. Opera-
tion, chemotherapy, radiation, and immunotherapy
have been used for this disease, but the overall
therapeutic result is still unsatisfactory. At present
operative intervention is indicated in patients in the
early stages to achieve a complete cure. It is thus
important to gather data on the perioperative mor-
tality in lung cancer for improving outcome and
selecting an optimal therapy.
The Lung Cancer Study Group (LCSG) published
their detailed analysis on 30-day operative mortality
for lung resections in a large population comprising
2220 lung cancer cases in North America in 1983.1
In this report the 30-day operative mortalities were
3.7% in the overall population, 6.2% for pneumo-
nectomy, 2.9% for lobectomy, and 7.1% for the
Table I. Thirty-day operative mortality with
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Total 7099 93 1.3
Table II. Thirty-day operative mortality with
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Table III. Causes of death within 30 days of
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patients 70 years of age or older. The data have been
referred to as a standard for analysis of operative
mortality in lung cancer.
Since then, there have been some reports on
operative mortalities in groups with a relatively
small number of cases,2, 3 aged patients,2-7 limited
operative procedures,8, 9 and selected clinical
stage.10, 11 However, no study has been done on the
operative mortality in lung cancer in a large popu-
lation comprising as many as several thousand cases,
except for one.12 The operative mortality in this
report, however, is based on discharge abstracts, not
on the data directly collected from attending doc-
tors. Furthermore, the observation periods are long
in many of the previous reports.2, 6, 7
This report was composed of more than 7000
cases, and the observation period was 1 year. Al-
though several reports have pointed out that the
operative outcome at selected institutions, such as
university hospitals, would not reflect the level of
general medical practice,5, 12 the institutions partic-
ipating in our study ranged from national centers
and university hospitals to institutions performing
fewer cases. We report on one of the largest analy-
ses made to date about the operative mortality in
lung cancer and describe the present status of
surgery in Japan.
Although the proportion of patients 70 years old
or older, commonly with more complications, in-
creased from 20.4% to 32.8%, the mortality in the
whole series decreased greatly from 3.7% to 1.3% in
our study compared with the LCSG report in 1983.
Such improvement may have resulted from the
decreased proportion of pneumonectomy (from
25.6% to 8.3%), the increased proportion of lobec-
tomy (from 67.9% to 79.0%), and the reduction in
mortalities for pneumonectomy (from 6.2% to
3.2%), lobectomy (from 2.9% to 1.2%), the group
70 to 79 years old (from 7.0% to 2.0%), and the
group 80 years old or older (from 8.1% to 2.2%),
although the data in the elderly in the LCSG report
were for lung resection.
The mortalities were 6.8% to 10.1% for pneumo-
nectomy2, 3, 12 and 3.4% to 4.0% for lobectomy2, 3, 12
in the literature; in our study the mortalities were
3.2% for the former and 1.2% for the latter (Table
IV). Compared with the mortalities of 4.9% to
17.0% for the patients 70 years old or older2-5 and
3.0% to 15.0% for the patients 80 years old or
older6, 7 in the literature (some data are for lung
resection as indicated in Table V ), our mortalities
were 2.1% and 2.2%, respectively. Mortalities in our
survey were obviously low.
The possible reasons for such a low perioperative
mortality are increasing cases in the early stages,
resulting from the wide use of computed tomogra-
phy and other diagnostic modalities13; improve-
ments in operative techniques, anesthesia, circula-
tory, and respiratory management; and control of
postoperative infection. Downstaging by induction
therapy also may have contributed to the reduced
mortality.
The pneumonectomy rate in this study was as low
as 8.3%. The operative indications for lung cancer in
Japan are as follows. Patients with non-small-cell
lung cancer in clinical stage I to IIIA are generally
operated on, some patients with non-small-cell lung
cancer in clinical stage IIIB (T4) with preoperative
tumor reduction by induction therapy are operated
on. Some patients with small-cell lung cancer in
clinical stage I are also operated on. The others are
not treated surgically.
In Japan, operations for lung cancer in clinical
stage I have increased and those for patients in
clinical stage IIIA have decreased13 because of the
nationwide mass screening system. Moreover, sur-
geons generally try bronchoplasty or pulmonary
arterioplasty to avoid pneumonectomy and conserve
Table IV. No. of operations and mortality for pneumonectomy and lobectomy in recent literature
Reference No. Year Years analyzed
Pneumonectomy Lobectomy
No. Mortality (%) No. Mortality (%)
1 1983 1979-1981 569 6.2 1058 2.9
2 1988 1970-1985 287 6.9 352 4.0
3 1991 1980-1987 191 6.8* 280 3.9*
12† 1992 1983-1986 1529 10.1‡ 6569 3.4‡
Present study 1997 1994 586 3.2 5609 1.2
*Defined as any death in the hospital after operation, regardless of length of time, or any death at home occurring within 30 days of operation.
†Data from California hospital discharge abstracts.
‡Defined as inhospital deaths within 30 days after resection.
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postoperative lung function.14 These are some of
reasons for the low rate of pneumonectomy.
Compared with the data from the LCSG,1 the
causes of deaths have shifted from bronchopleural
fistula and empyema to pneumonia and respiratory
failure. As described above, operations for patients
in the early stages have increased in Japan. This has
brought the reduction of pneumonectomies and
may have lessened bronchopleural fistula. Further-
more, although we do not have exact proof, the
improvement of operative procedures and instru-
ments or the appearance of drug-resistant patho-
gens may also account for this.
In conclusion, the results of our study on opera-
tive mortality in lung cancer in a large population
exceeding 7000 cases could be used as a standard for
discussing therapeutic outcome in patients with lung
cancer. Thirty-day operative mortalities in our series
were satisfactorily low: 1.3% in the overall popula-
tion, 3.2% for pneumonectomy, 1.2% for lobectomy,
and 2.1% for the patients 70 years old or older.
We are grateful to all the members of the Japanese
Association for Chest Surgery for their contribution in
collecting valuable data.
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Table V. No. of operations and mortalities for thoracotomy in the elderly in recent literature
Reference No. Year Years analyzed
Age $70 Age $80
No. Mortality (%) No. Mortality (%)
1* 1983 1979-1981 453 7.1 37 8.1
4 1987 1977-1984 64 9.4 — —
2 1988 1970-1985 71 11.2 — —
3* 1991 1980-1987 81 4.9† — —
5*‡ 1991 1983-1985 94 17.0§ — —
6 1994 1981-1991 — — 40 15.0\
7* 1994 1974-1991 — — 33 3.0
Present study 1997 1994 2330 2.1 225 2.2
*Data for lung resection.
†Defined as any death in a hospital after operation, regardless of length of time, or any death at home occurring within 30 days after operation.
‡Data from Medicare hospital claims records.
§Defined as deaths within 30 days of admission.
\Defined as death within 30 days of operation or anytime during hospitalization.
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